ZFIN ID: ZDB-PUB-001018-5
Neoplasia in zebrafish (Danio rerio) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages
Spitsbergen, J.M., Tsai, H.W., Reddy, A., Miller, T., Arbogast, D., Hendricks, J.D., and Bailey, G.S.
Date: 2000
Source: Toxicologic pathology 28(5): 705-715 (Journal)
Registered Authors: Bailey, George, Reddy, Ashok, Spitsbergen, Jan
Keywords: none
MeSH Terms: 9,10-Dimethyl-1,2-benzanthracene/administration & dosage; 9,10-Dimethyl-1,2-benzanthracene/toxicity*; Animals; Body Weight; Carcinogens/administration & dosage (all 27) expand
PubMed: 11026607 Full text @ Toxicol. Pathol.
ABSTRACT
Using zebrafish, Danio rerio, initial pioneering work in the 1960s revealed carcinogen responsiveness of fish, yet very few subsequent tumorigenesis investigations have utilized this species. We exposed embryos (60 hours postfertilization) and fry (3 week posthatch) to 7,12-dimethylbenz[a]anthracene (DMBA) by immersion in aqueous solutions for 24 hours, at concentrations of 0-1 or 0-5 ppm (mg/L), respectively. Juvenile zebrafish 2 months posthatch were fed a diet containing 0-1,000 ppm DMBA for 4 months. Fish were sampled for histologic evaluation at 7-12 months after the onset of carcinogen treatment. Fry were most responsive to DMBA and showed the widest diversity of target tissues and histologic types of neoplasia, having several types of epithelial, mesenchymal, and neural neoplasia. The principal target tissues for carcinogenic response were liver following embryo or fry exposure, with gill and blood vessel the second and third most responsive tissues in fry. Intestine was the primary target and gill a secondary target in fish that received dietary DMBA as juveniles. These studies indicate that young zebrafish are most responsive to DMBA, showing a greater diversity of neoplasm types than rainbow trout. Thus, zebrafish are a valuable model system in which to study mechanistic aspects of the carcinogenesis process.
ADDITIONAL INFORMATIONNo data available